Production (Stage)
Hoth Therapeutics, Inc.
HOTH
$1.19
-$0.11-8.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.52M | 1.06M | 1.23M | 1.08M | 1.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.48M | 2.38M | 2.13M | 1.65M | 2.16M |
| Operating Income | -3.48M | -2.38M | -2.13M | -1.65M | -2.16M |
| Income Before Tax | -3.48M | -2.38M | -2.13M | -1.63M | -2.15M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.48M | -2.38M | -2.13M | -1.63M | -2.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.48M | -2.38M | -2.13M | -1.63M | -2.15M |
| EBIT | -3.48M | -2.38M | -2.13M | -1.65M | -2.16M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.27 | -0.33 | -0.31 | -0.24 | -0.49 |
| Normalized Basic EPS | -0.17 | -0.20 | -0.19 | -0.15 | -0.30 |
| EPS Diluted | -0.27 | -0.33 | -0.31 | -0.24 | -0.49 |
| Normalized Diluted EPS | -0.17 | -0.20 | -0.19 | -0.15 | -0.30 |
| Average Basic Shares Outstanding | 12.73M | 7.31M | 6.90M | 6.88M | 4.40M |
| Average Diluted Shares Outstanding | 12.73M | 7.31M | 6.90M | 6.88M | 4.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |